Anti-MMP-16 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody against matrix metalloproteinase-16 (MMP-16, MT3-MMP), validated for Western blot in human tissue.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Monkey, Dog
UniProt
P51512
Size
100ug
Cat. #
RP1MMP16

In stock

SKU
RP-MMP16

Options

As low as: $130.00

Target Overview

Matrix metalloproteinase-16 (MMP-16, EC 3.4.24.-, UniProt P51512) is a membrane-type matrix metalloproteinase (MT-MMP) that functions as a cell surface endopeptidase involved in extracellular matrix remodeling. Also known as MT3-MMP or MMP-X2, this 607-amino acid protease is anchored to the plasma membrane where it degrades collagen type III, fibronectin, and activates progelatinase A (MMP-2). MMP-16 plays a documented role in vascular remodeling and tissue invasion processes. The enzyme exists in multiple isoforms; a shorter isoform retains fibronectin and collagen III cleavage activity but does not cleave collagen types I, II, IV, or V under standard conditions. Upon interaction with chondroitin sulfate proteoglycan 4 (CSPG4), MMP-16 facilitates type I collagen degradation in melanoma invasion models. Researchers studying tumor metastasis, angiogenesis, wound healing, and connective tissue remodeling use MMP-16 as a marker and mechanistic target.

Background

MMP-16 belongs to the membrane-type matrix metalloproteinase subfamily, which differs from secreted MMPs by possessing a transmembrane domain that localizes proteolytic activity to the cell surface. This spatial restriction enables highly localized matrix degradation during cell migration, vascular sprouting, and tissue invasion. The catalytic domain degrades fibronectin and collagen type III efficiently, while the hinge region—targeted by several Triple Point Biologics clones—connects functional domains and is accessible for antibody recognition in multiple assay formats. Recent studies have expanded the biological context of MMP-16. Yang et al. (2026) demonstrated that exosome-transmitted lncRNA SNHG1 promotes prostate cancer bone metastasis through a YBX1/MMP16 signaling axis, implicating MMP-16 in metastatic colonization of bone tissue. Zhang et al. (2026) explored the synergistic collagen degradation activity of MMP-3 and MMP-16 in post-mortem muscle tissue, revealing coordinated protease mechanisms in extracellular matrix turnover. Mendelian randomization approaches have linked circulating MMP levels, including MMP-16, to disease phenotypes such as diabetic retinopathy and schizophrenia, suggesting that MMP-16 may serve as a biomarker in systemic inflammatory or neurovascular pathologies. Triple Point Biologics offers five rabbit polyclonal antibodies raised against the MMP-16 hinge region, validated in human samples and predicted to cross-react with mouse, rat, nonhuman primate, and canine orthologs. These reagents are suitable for Western blot, immunohistochemistry, and immunofluorescence applications in matrix biology and cancer metastasis research.

References

  1. Yang T et al. (2026) Exosome-transmitted long noncoding RNA SNHG1 promotes prostate cancer bone metastasis via YBX1/MMP16 axis. Cell Death Discov. PubMed · DOI
  2. Zhang TB et al. (2026) Mechanistic Insights into Synergistic Collagen Degradation by MMP-3 and MMP-16 in Post-Mortem Abalone Muscle. J Agric Food Chem. PubMed · DOI
  3. Qiu X et al. (2026) Causal relationship between matrix metalloproteinases and diabetic retinopathy: A bidirectional two-sample Mendelian randomization study. Medicine (Baltimore). PubMed · DOI
  4. Lin J et al. (2026) Proteome-wide Mendelian randomization and colocalization analyses identify potential biomarkers for schizophrenia. Front Psychiatry. PubMed · DOI
  5. Zhao S et al. (2026) Integrative Analysis of Whole-Genome Bisulfite Sequencing and RNA-Seq in Skeletal Muscle of Xin'anjiang Water Buffalo. Animals (Basel). PubMed · DOI

Additional Specifications

Gene Symbol MMP16
UniProt ID P51512
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Monkey, Dog
Pack Size 100ug
Immunogen (Hinge region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 281-340.
Immunogen (Carboxy end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 557-607.
Immunogen (Furin cleavage site)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 111-122.
Immunogen (Propeptide region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 32-119.
Immunogen (Â Aminoterminal end of active enzyme)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 120-170.
Alternate Names Matrix metalloproteinase-16, MMP-16, MMP-X2, Membrane-type matrix metalloproteinase 3, MT-MMP 3, MTMMP3, Membrane-type-3 matrix metalloproteinase, MT3-MMP, MT3MMP, EC 3.4.24.-

Frequently Asked Questions

What molecular weight band should I expect for MMP-16 on Western blot?

Full-length MMP-16 (MT3-MMP) runs at approximately 64 kDa on reducing SDS-PAGE, corresponding to the 607-amino acid membrane-anchored form. You may also detect a prominent band near 52-55 kDa representing the shorter isoform, which retains fibronectin and collagen III cleavage activity. In some cell lysates, particularly from melanoma or vascular tissues with active remodeling, you may observe additional bands corresponding to processed or shed forms. The banding pattern depends on cell type, activation state, and whether you are analyzing whole-cell lysates versus membrane-enriched fractions. Always include a known MMP-16-expressing cell line as a positive control.

What starting dilution should I use for MMP-16 Western blot detection?

We recommend starting at 1:1000 dilution in blocking buffer containing 5 percent non-fat dry milk or BSA in TBST for overnight incubation at 4°C. This polyclonal antibody performs well within the 1:500 to 1:2000 range, but optimal dilution depends on MMP-16 expression level in your sample. Membrane-type MMPs like MMP-16 are often enriched in membrane fractions, so cytosolic preparations may require higher antibody concentration or longer exposure. Titrate against your specific lysate type and include a lysate from HT-1080 fibrosarcoma or melanoma cells as a high-expression control to bracket signal.

Does this MMP-16 antibody distinguish between the full-length and shorter isoforms?

This polyclonal antibody was raised against a region spanning residues within the catalytic and hinge domains, so it recognizes both the full-length 607-amino acid membrane-anchored form and the shorter isoform that retains fibronectin and collagen III cleavage activity. You will typically detect both on Western blot as distinct bands near 64 kDa and 52-55 kDa. If your experiment requires isoform-specific detection, you will need to confirm the epitope map or select an antibody targeting the unique C-terminal region present only in the full-length protein. For most extracellular matrix remodeling studies, detecting both isoforms is informative.

Is this antibody validated for mouse and rat MMP-16 detection?

Human MMP-16 has been validated experimentally with this antibody. Mouse and rat cross-reactivity are predicted based on sequence homology in the immunogen region but have not been formally validated in our hands. Human and mouse MMP-16 share approximately 85 percent sequence identity overall, with higher conservation in the catalytic domain. If you are working with rodent samples, plan to titrate the antibody and include a positive control such as transfected lysate or tissue known to express MMP-16, like aorta or tumor xenografts undergoing active remodeling. Empirical testing is the only way to confirm signal specificity in non-validated species.

What sample preparation is best for detecting membrane-bound MMP-16?

Because MMP-16 is a membrane-type MMP anchored to the plasma membrane via a transmembrane domain, enrichment improves sensitivity. Use RIPA or 1 percent Triton X-100 lysis buffer supplemented with protease inhibitors; avoid mild lysis conditions that leave membranes intact. For maximum yield, consider membrane fractionation kits or ultracentrifugation protocols that pellet membrane fractions. Load 20-40 micrograms of total protein per lane or 5-10 micrograms of membrane-enriched lysate. Avoid boiling samples excessively, as this can aggregate membrane proteins; heating at 70°C for 10 minutes in reducing sample buffer is sufficient for most applications.

Can I use this antibody for immunohistochemistry on tissue sections?

Yes, This antibody is validated for Western blot; IHC application data is in progress. For paraffin-embedded sections, antigen retrieval is typically required; citrate buffer (pH 6.0) heat-induced epitope retrieval works well for most MT-MMPs. Use the antibody at dilutions between 1:100 and 1:400 depending on tissue MMP-16 expression and detection system sensitivity. MMP-16 localizes to the cell surface and invading front in tumors, and to endothelial and smooth muscle layers in vascular tissue. Include appropriate negative controls such as primary antibody omission and isotype control. For frozen sections, fixation with 4 percent paraformaldehyde or acetone generally preserves epitope accessibility without retrieval.

How should I store this MMP-16 antibody to maintain activity?

Store the antibody at -20°C in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase background. The antibody is supplied at 100 micrograms in a stabilized buffer; upon receipt, aliquot into working volumes suitable for 4-6 experiments to minimize freeze-thaw. For short-term use within 1-2 weeks, diluted antibody can be stored at 4°C in the presence of 0.02 percent sodium azide, though we recommend preparing fresh dilutions for each experiment when possible. Do not store diluted antibody long-term without preservative. Properly stored aliquots remain stable for at least 12 months at -20°C.

What are suitable positive and negative controls for MMP-16 experiments?

For positive controls, use lysates from HT-1080 fibrosarcoma cells, melanoma cell lines such as A375, or primary human vascular smooth muscle cells stimulated with TGF-beta or PDGF, all of which express MMP-16 during extracellular matrix remodeling. Membrane fractions from these cells yield the strongest signal. For negative controls, use cell lines with minimal or absent MMP-16 expression, or pre-incubate the antibody with blocking peptide if available. Knockdown or knockout lysates provide the best specificity control. In IHC, normal tissues with low MMP-16 such as liver or kidney cortex serve as useful negative anatomical controls, while tumor invasion fronts or atherosclerotic plaques are positive.

Western blot validation for RP-MMP16 — 5 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

MMP-16: Hinge region — WB validation
WB · Panel 1 MMP-16: Hinge region
MMP-16: Carboxy end — WB validation
WB · Panel 2 MMP-16: Carboxy end
MMP-16: Furin cleavage site — WB validation
WB · Panel 3 MMP-16: Furin cleavage site
MMP-16: Propeptide region — WB validation
WB · Panel 4 MMP-16: Propeptide region
MMP-16: Â Aminoterminal end of active enzyme — WB validation
WB · Panel 5 MMP-16: Â Aminoterminal end of active enzyme

Custom validation studies available on request — contact us.

Also known as:

  • Matrix metalloproteinase-16
  • MMP-16
  • MMP-X2
  • Membrane-type matrix metalloproteinase 3
  • MT-MMP 3
  • MTMMP3
  • Membrane-type-3 matrix metalloproteinase
  • MT3-MMP
  • MT3MMP
  • EC 3.4.24.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →